Congenital kaposiform hemangioendothelioma with kasabach-merritt phenomenon successfully treated with low-dose radiation therapy

Yogangi Malhotra, Catherine S. Yang, Joseph McNamara, Richard J. Antaya

Research output: Contribution to journalArticle

16 Scopus citations


Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.

Original languageEnglish (US)
Pages (from-to)595-598
Number of pages4
JournalPediatric Dermatology
Issue number5
Publication statusPublished - Jan 1 2014


ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Cite this